» Articles » PMID: 8929862

Transforming Growth Factor-beta Protein and Messenger RNA Expression is Increased in the Closing Ductus Arteriosus

Overview
Journal Pediatr Res
Specialties Biology
Pediatrics
Date 1996 Mar 1
PMID 8929862
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

In full-term newborns, permanent closure of the ductus arteriosus is associated with the formation of a neointima that is characterized by extracellular matrix deposition and smooth muscle cell migration. Transforming growth factor-beta (TGF-beta), a potent modulator of extracellular matrix deposition and smooth muscle cell migration, has been found to play a role in the remodeling associated with several forms of vascular disease. We examined the protein and mRNA expression of the three mammalian isoforms of TGF-beta (TGF-beta1, TGF-beta2, and TGF-beta3) during ductus arteriosus closure in full-term lambs. We found that the temporal changes and cellular localization of the proteins and mRNAs of all three TGF-beta isoforms were similar. TGF-beta proteins and mRNAs were present in very low levels in the late-gestation fetal ductus. Within 24 h of delivery, there was enhanced expression of TGF-beta in the newly forming neointima and outer muscle media; this continued to increase over the next 10 d. Increased expression of TGF-beta in the inner muscle media and adventitia lagged behind that of the neointima and outer muscle media. TGF-beta was not found in the luminal endothelial cells at any time. In contrast to the pattern described above, the appearance of TGF-beta protein differed from that of mRNA in the vasa vasorum of the ductus wall. After delivery, there was an increase in TGF-beta immunoreactivity in the smooth muscle cell layers of the vasa vasorum without any concurrent mRNA expression. The appearance of TGF-beta at the time of ductus closure suggests an important role for this growth factor in the reorganization of the ductus wall after birth.

Citing Articles

Keeping the Ductus Arteriosus Patent: Current Strategy and Perspectives.

Chatziantoniou A, Rorris F, Samanidis G, Kanakis M Diagnostics (Basel). 2025; 15(3).

PMID: 39941172 PMC: 11817600. DOI: 10.3390/diagnostics15030241.


Role of Extracellular Matrix in Pathophysiology of Patent Ductus Arteriosus: Emphasis on Vascular Remodeling.

Lin T, Yeh J, Hsu J Int J Mol Sci. 2020; 21(13).

PMID: 32635482 PMC: 7369762. DOI: 10.3390/ijms21134761.


Molecular Mechanisms for Regulating Postnatal Ductus Arteriosus Closure.

Hung Y, Yeh J, Hsu J Int J Mol Sci. 2018; 19(7).

PMID: 29941785 PMC: 6073350. DOI: 10.3390/ijms19071861.


Sox18 preserves the pulmonary endothelial barrier under conditions of increased shear stress.

Gross C, Aggarwal S, Kumar S, Tian J, Kasa A, Bogatcheva N J Cell Physiol. 2014; 229(11):1802-16.

PMID: 24677020 PMC: 4117725. DOI: 10.1002/jcp.24633.


Association between blood spot transforming growth factor-β and patent ductus arteriosus in extremely low-birth weight infants.

Natarajan G, Shankaran S, McDonald S, Das A, Ehrenkranz R, Goldberg R Pediatr Cardiol. 2012; 34(1):149-54.

PMID: 22684193 PMC: 3704212. DOI: 10.1007/s00246-012-0404-7.